FNP 511 Exam Questions and Answers Graded
A+
Leik, Maria T. Codina, MSN, ARNP, FNP-C, AGPCNP-BC. Family Nurse Practitioner
Certification Intensive Review, Fourth Edition (p. 1244). Springer Publishing Company. Kindle
Edition. ✔✔B) Respiratory system. Chronic use of NSAIDs is associated with increased risk
of ulcers, perforation, bleeding of the gastrointestinal tract, heart attacks, cardiovascular
damage, strokes, acute 638interstitial nephritis and kidney injury, and liver damage. It does not
affect the lungs or the pulmonary system.
Leik, Maria T. Codina, MSN, ARNP, FNP-C, AGPCNP-BC. Family Nurse Practitioner
Certification Intensive Review, Fourth Edition (p. 1288). Springer Publishing Company.
Kindle Edition.
12. 645 A 67-year-old female patient complains of progressive dyspnea, minimal cough, and a
10-lb weight loss over the past 3 months. The nurse practitioner notes decreased posterior breath
sounds, the use of accessory muscles to breathe, temperature of 98.8°F, and respirations of
24 breaths/minute. The nurse practitioner suspects:
A. Emphysema
, B. Chronic bronchitis
C. Respiratory infection
D. Pneumonia
Leik, Maria T. Codina, MSN, ARNP, FNP-C, AGPCNP-BC. Family Nurse Practitioner
Certification Intensive Review, Fourth Edition (pp. 1300-1301). Springer Publishing Company.
Kindle Edition. ✔✔A) Emphysema. Emphysema presents with shortness of breath, minimal
cough, and decreased heart and lung sounds. Patients use pursed-lip breathing, and use of
accessory muscles is prominent. Chronic bronchitis is characterized by a productive cough,
wheezing, and coarse crackles. A respiratory infection and/or pneumonia presents with fever
and new onset of symptoms.
Leik, Maria T. Codina, MSN, ARNP, FNP-C, AGPCNP-BC. Family Nurse Practitioner
Certification Intensive Review, Fourth Edition (p. 1344). Springer Publishing Company. Kindle
Edition.
Which first-line treatment should be administered when treating a patient with chronic
obstructive pulmonary disease (COPD) category C?
A. Long-acting muscarinic agonist (LAMA)
B. Short-acting beta2-agonist (SABA) C. Long-acting beta2-agonist (LABA)
D. Short-acting muscarinic agonist (SAMA)
Leik, Maria T. Codina, MSN, ARNP, FNP-C, AGPCNP-BC. Family Nurse Practitioner
Certification Intensive Review, Fourth Edition (p. 1303). Springer Publishing Company. Kindle
Edition. ✔✔A) Long-acting muscarinic agonist (LAMA). LAMA is the first line of
treatment for chronic obstructive pulmonary disease (COPD) in category C. For category A, a
SABA is recommended. A LABA is used for category B. SAMA only blocks the muscarinic
effects.
Leik, Maria T. Codina, MSN, ARNP, FNP-C, AGPCNP-BC. Family Nurse Practitioner
Certification Intensive Review, Fourth Edition (p. 1347). Springer Publishing Company. Kindle
Edition.